Ovid Therapeutics Inc (OVID)

Ovid Therapeutics Inc (OVID) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	29.91% 0.1416	0.109	0.075	0.0662	0.0889
Operating Expenses	51.02% 18.33	12.14	14.25	14.96	12.22
Benefits Costs and Expenses	36.11% 15.46	11.36	12.48	13.42	-26.62
Costs And Expenses	36.11% 15.46	11.36	12.48	13.42	-26.62
Operating Income/Loss	51.21% -18.19	-12.03	-14.17	-14.89	-12.17
Income/Loss From Continuing Operations Before Tax	36.17% -15.32	-11.25	-12.41	-13.36	26.66
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	36.17% -15.32	-11.25	-12.41	-13.36	26.66
Net Income/Loss	36.17% -15.32	-11.25	-12.41	-13.36	-11.50
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.95% 0.0361	70.62	70.53	70.49	0.0162
Diluted Average Shares	99.95% 0.0361	70.62	70.53	70.49	0.0162
Basic Earnings Per Share	37.50% -0.22	-0.16	-0.18	-0.19	-0.16
Diluted Earnings Per Share	37.50% -0.22	-0.16	-0.18	-0.19	-0.16
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-